Order Article Reprints

Pitts TM, Simmons DM, Bagby SM, Hartman SJ, Yacob BW, Gittleman B, Tentler JJ, Cittelly D, Ormond DR, Messersmith WA, et al. Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer. Cancers. 2020; 12(3):719. https://doi.org/10.3390/cancers12030719

Pitts, Todd M., Dennis M. Simmons, Stacey M. Bagby, Sarah J. Hartman, Betelehem W. Yacob, Brian Gittleman, John J. Tentler, Diana Cittelly, D. Ryan Ormond, Wells A. Messersmith, and et al. 2020. "Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer" Cancers 12, no. 3: 719. https://doi.org/10.3390/cancers12030719

Pitts, T. M., Simmons, D. M., Bagby, S. M., Hartman, S. J., Yacob, B. W., Gittleman, B., Tentler, J. J., Cittelly, D., Ormond, D. R., Messersmith, W. A., Eckhardt, S. G., & Diamond, J. R. (2020). Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer. Cancers, 12(3), 719. https://doi.org/10.3390/cancers12030719